Daewoong pharmaceutical

069620.KO

100.24 USD

-0.91

-0.90%

Overview

Last close

100.24 usd

Market cap

1.15B usd

52 week high

134.42 usd

52 week low

76.68 usd

Target price

145.8 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.0862

Price/Book Value

1.696

Enterprise Value

1.61B usd

EV/Revenue

1.5042

EV/EBITDA

9.2527

Key financials

Revenue TTM

1.07B usd

Gross Profit TTM

559.23M usd

EBITDA TTM

167.65M usd

Earnings per Share

N/A usd

Dividend

0.41 usd

Total assets

1.64B usd

Net debt

456.36M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.